National Cancer Control Programme

Diagnosis, staging and treatment of patients with Oesophageal or Oesophagogastric Cancer

Guideline Consultation Process

The draft clinical section of “Diagnosis, staging and treatmentof patients withOesophageal or Oesophagogastric Cancer” is available for consultation and reviewwithin Ireland from November 24th2017until January8th 2018.

For all feedback and queries please, complete the feedback and the conflict of interest form and email it to

In order for feedback to be considered, the conflict of interest section of the form must be completed.

Note: Permissions have been sought from International Guideline Groups to quote their content where applicable, with appropriate acknowledgement. If permission is not granted the relevant sections will be edited accordingly prior to publication.

National Cancer Control Programme – Tumour Groups

Feedback on the draft guideline

Guideline: / Diagnosis, staging and treatment of patients with Oesophageal or Oesophagogastric Cancer
Name of person providing feedback:
Hospital/organisation and discipline:
Contact details:
Date:
Which clinical question(s) do you wish to address?
Clinical Question(s)
Which part of the question(s) do you wish to address?

Evidence Statement
Recommendations
Please give a brief description of your suggested amendment.
Please list and/or attach supporting evidence for the change/amendment.

Please return your feedback(incl. supporting evidence where applicable) & conflict of interest form to by 8th January 2017

1

Declaration of Interest
Indicate why you are making this declaration:Mark with an ‘X’ as appropriate or add if ‘Other’ is selected
NCEC on appointment/annual declaration / NCEC Prioritisation team
NCEC subgroup on appointment/annual declaration / NCEC Quality assurance team
CEU/PSU on appointment/annual declaration / Research contractor on appointment/annual declaration
Guideline development group on appointment/annual declaration / Other:
National clinical audit governance committee on appointment/annual declaration
Name of the clinical guideline/audit (when applicable):
Diagnosis, staging and treatment of oesophageal and oesophago-gastric cancer
Interests to be declared
By signing this declaration form I consent to the CEU holding and processing my data for the purpose of managing conflicts of interests. I understand that this declaration will be made available in summary on the published guideline/audit (as applicable) and made available on the NCEC website. Furthermore, I understand that this form may be released under a Freedom of Information (2014) request. I am aware that failure to make a full disclosure may result in withdrawal of my membership.
Registration number: / Print Name: BLOCK LETTERS
Date:
Signature:
For reference person use only (Chair or other):
Noted by
Signature: / Print Name: BLOCK LETTERS
Date:
Action taken: refer to possible control/actions in policy

Guidance to persons completing the NCEC declarations of interest form

  1. You must first read and be familiar with the content of the current version of the NCEC policy Conflicts of Interest (v2) accompanying (and available on website or on request) before you complete and sign this declaration form. You are asked to familiarise yourself in particular with the Types of interest section of the policy and note that examples are given in Table 1. If the need arises you may seek guidance from the reference person identified in Table 3 of policy.
  2. In summary, a conflict of interest is any interest that could potentially influence or be perceived to influence the content, including the endorsement of National Clinical Guidelines or National Clinical Audit and any interest that could result in bias in the other work or decision making processes. You must consider and declare all financial, intellectual, academic/clinical and competing interests. If in doubt, please declare all interests.
  3. The time period for declaring relevant interests is 12 months before joining the NCEC or other group of the NCEC and for the duration of your membership of the committee/group /panel or other group acting on behalf of the NCEC.
  4. At the start of a meeting at designated time intervals (e.g. annually), the Chair will undertake a review of completed declaration of interest forms and will co-sign them, noting the conflict/potential conflict and decide on the appropriate action to be taken if required.
  5. The Clinical Effectiveness Unit (CEU) in the Department of Health will act in compliance with the Data Protection Acts 1988 & 2003.
  6. The NCEC intends to publish a Register of interests on its website in due course (work in progress).

Making a declaration using the form

  1. You may save this form to your desktop and complete on screen before printing, signing and returning by email, by post or in person at a meeting. Alternatively you can complete by hand.
  2. If you have no conflicts to declare you should return a ‘Nil’ signed form.
  3. In addition to completing the NCEC’s forms at defined intervals (see Table 2 of policy) responsibility lies with you to renew a declaration if/when interests change or a specific conflict emerges unexpectedly. This will be facilitated by the Chair who at the start of every meeting will invite members to review the agenda and assess the risk of any emergent conflict of interest. If you have any concerns you must make a verbal declaration. The minutes of the meeting will reflect this occurrence and you will be asked to complete a new declaration form.

1